Free Trial

Belluscura (BELL) Competitors

GBX 1.51 -0.04 (-2.58%)
As of 09:49 AM Eastern

BELL vs. IHC, AVO, MHC, RUA, SUN, DEMG, NIOX, SN, MXCT, and EKF

Should you be buying Belluscura stock or one of its competitors? The main competitors of Belluscura include Inspiration Healthcare Group (IHC), Advanced Oncotherapy (AVO), MyHealthChecked (MHC), RUA Life Sciences (RUA), Surgical Innovations Group (SUN), Deltex Medical Group (DEMG), NIOX Group (NIOX), Smith & Nephew (SN), MaxCyte (MXCT), and EKF Diagnostics (EKF). These companies are all part of the "medical devices" industry.

Belluscura vs.

Belluscura (LON:BELL) and Inspiration Healthcare Group (LON:IHC) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their media sentiment, risk, analyst recommendations, community ranking, dividends, earnings, profitability, valuation and institutional ownership.

6.3% of Belluscura shares are owned by institutional investors. Comparatively, 46.1% of Inspiration Healthcare Group shares are owned by institutional investors. 56.3% of Belluscura shares are owned by insiders. Comparatively, 31.8% of Inspiration Healthcare Group shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Inspiration Healthcare Group has higher revenue and earnings than Belluscura. Inspiration Healthcare Group is trading at a lower price-to-earnings ratio than Belluscura, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Belluscura£2.87M1.33-£29.55M-£9.37-0.16
Inspiration Healthcare Group£42.87M0.34-£12.20M-£14.58-1.14

Inspiration Healthcare Group received 103 more outperform votes than Belluscura when rated by MarketBeat users.

CompanyUnderperformOutperform
BelluscuraN/AN/A
Inspiration Healthcare GroupOutperform Votes
103
68.21%
Underperform Votes
48
31.79%

In the previous week, Inspiration Healthcare Group's average media sentiment score of 1.29 beat Belluscura's score of 0.00 indicating that Inspiration Healthcare Group is being referred to more favorably in the news media.

Company Overall Sentiment
Belluscura Neutral
Inspiration Healthcare Group Positive

Belluscura has a beta of 1.05, indicating that its stock price is 5% more volatile than the S&P 500. Comparatively, Inspiration Healthcare Group has a beta of 0.09, indicating that its stock price is 91% less volatile than the S&P 500.

Inspiration Healthcare Group has a net margin of -28.46% compared to Belluscura's net margin of -1,030.73%. Inspiration Healthcare Group's return on equity of -34.30% beat Belluscura's return on equity.

Company Net Margins Return on Equity Return on Assets
Belluscura-1,030.73% -102.62% -43.53%
Inspiration Healthcare Group -28.46%-34.30%-3.47%

Summary

Inspiration Healthcare Group beats Belluscura on 8 of the 13 factors compared between the two stocks.

Remove Ads
Get Belluscura News Delivered to You Automatically

Sign up to receive the latest news and ratings for BELL and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BELL vs. The Competition

MetricBelluscuraMedical Devices IndustryMedical SectorLON Exchange
Market Cap£3.81M£3.54B£5.63B£2.60B
Dividend YieldN/A2.44%4.57%4.82%
P/E Ratio-0.1679.2123.33141.21
Price / Sales1.33130.74388.46281,678.09
Price / Cash8.0015.9938.1627.94
Price / Book0.133.806.894.61
Net Income-£29.55M£126.02M£3.20B£5.78B
7 Day Performance-4.13%-2.96%-3.02%1.37%
1 Month Performance-20.53%-6.88%1.63%7.22%
1 Year Performance-91.84%-12.44%9.74%108.14%

Belluscura Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BELL
Belluscura
N/AGBX 1.51
-2.6%
N/A-92.1%£3.81M£2.87M-0.1624Gap Down
High Trading Volume
IHC
Inspiration Healthcare Group
N/AGBX 16.37
-2.3%
N/A-42.3%£14.18M£42.87M-1.12224Gap Down
AVO
Advanced Oncotherapy
N/AN/AN/AN/A£9.50MN/A-25.003,900Gap Down
MHC
MyHealthChecked
N/AGBX 15
-3.2%
N/A+23.8%£7.81M£9.43M-7.4816Gap Up
RUA
RUA Life Sciences
N/AGBX 12.08
-1.4%
N/A+24.7%£7.49M£4.05M-2.8148
SUN
Surgical Innovations Group
N/AGBX 0.55
+0.2%
N/A+2.7%£5.14M£12.54M-21.1180News Coverage
DEMG
Deltex Medical Group
N/AGBX 0.01
-71.4%
N/AN/A£187,000.00£1.76M-0.1537Gap Up
High Trading Volume
NIOX
NIOX Group
N/AGBX 60.80
-1.3%
N/A+16.4%£24.97B£3.53B2,509.1192
SN
Smith & Nephew
4.0879 of 5 stars
GBX 1,105
0.0%
GBX 4,607.50
+317.0%
+6.5%£12.11B£7.08B39.7818,452Insider Trade
High Trading Volume
MXCT
MaxCyte
N/AGBX 242.80
-2.9%
N/A-34.2%£320.51M£57.52M-8.9080Gap Down
EKF
EKF Diagnostics
N/AGBX 18.92
+0.9%
N/A-20.9%£84.08M£49.91M17.60356Earnings Report
Insider Trade
News Coverage
Positive News
Remove Ads

Related Companies and Tools


This page (LON:BELL) was last updated on 3/28/2025 by MarketBeat.com Staff
From Our Partners